HOME >> MEDICINE >> NEWS
From smoking to sumatriptan, researchers present important new findings on the impacts of drug metabolism

LOS ANGELES -- Pharmacologists from across the country and around the world will offer more than 350 presentations during the American Society for Clinical Pharmacology and Therapeutics annual meeting March 15-18 at the Century Plaza Hotel & Tower. They include:

Why do Chinese-Americans smoke less than whites?

It's one of the major curiosities in smoking behavior -- why one smoker is content with one or two cigarettes a day but another craves a pack a day or more. New research from Rachel Tyndale, MD, and her colleagues at the University of Toronto indicates that people with defects in the CYP2A6 gene tend to smoke about one-third fewer cigarettes per day than people without the defects. People with CYP2A6 defects metabolize nicotine slower, so they don't smoke as much. Neal Benowitz, MD, and colleagues at the University of California at San Francisco report that slow metabolism of nicotine due to CYP2A6 defects may explain why Chinese-Americans smoke less than whites. (Oral presentations)

Sweet News for Sickle Cell Anemia Sufferers

The artificial sweetener aspartame has been reported to be effective in counteracting the effects of abnormal hemoglobin that reduce oxygen in red blood cells, causing sickle cell anemia. However, appropriate doses for clinical use have not been determined. In a new study of 24 patients, researchers from Oklahoma Medical Research Foundation and Oklahoma University Health Sciences Center have determined an amount that remains effective for eight hours or longer. The findings are good news for sickle cell anemia patients, as few treatment drugs are available. (Poster PI-55).

Quick Relief for Adolescents with Migraine

Adults plagued by migraine headache have been able to obtain quick relief with a nasal spray of the drug sumatriptan since 1997. But that doesn't help the 8 million children and adolescents who suffer from migraines since clinicians have been uncertain about amounts
'"/>

Contact: Kirk Monroe
kmcpr@aol.com
202-789-8101
K-M Communications
14-Mar-2000


Page: 1 2

Related medicine news :

1. NHS stop-smoking services are insufficient to deliver national smoking targets
2. Study suggests smoking while pregnant may increase chromosomal abnormalities in fetal cells
3. Current daily smoking may be associated with increased risk for suicidal thoughts and attempts
4. School-based smoking prevention programs ineffective
5. Parents who quit smoking may influence their offspring to quit as young adults
6. Inpatient smoking cessation counseling is associated with early differences in mortality
7. NHLBI study shows smoking cessation programs improve survival
8. 14-year study finds that quitting smoking adds years to life
9. Campus can be effective site for anti-smoking efforts
10. Contrary to previous findings, smoking is detrimental to patients with Alzheimers
11. State policies decrease youth smoking, drinking and sex

Post Your Comments:
(Date:4/23/2014)... of endogenous neural precursor cells cannot alone compensate ... the perspective of neural plasticity, Dr. Yun Xiang ... observed the effects of functional electrical stimulation treatment ... of basic fibroblast growth factor and epidermal growth ... side. The researchers found that functional electrical stimulation ...
(Date:4/22/2014)... (Chicago) A recently FDA-approved device has been shown ... as much as 50 percent. When coupled with an ... Rush, the device facilitated the complete elimination of seizures ... in the decade-long clinical trials. , That,s good news ... in the U.S. living with epilepsy whose seizures can,t ...
(Date:4/22/2014)... all lung cancers are small cell lung cancers ... to chemotherapy. However, researchers at Virginia Commonwealth University ... the mechanisms leading to this resistance that may ... primarily by mediating B-cell lymphoma 2 (Bcl-2) family ... Depending on their function, this family of proteins ...
(Date:4/22/2014)... Hopkins scientists have found a way to block abnormal ... of atherosclerosis, the main cause of heart attacks and ... The condition develops when fat builds inside blood vessels ... greatly reducing their ability to feed oxygen-rich blood to ... series of experiments, described April 7 in the journal ...
(Date:4/22/2014)... massive health care spending, a new RAND study concludes ... incentivize pharmaceutical companies and device makers to develop products ... medical technologies and their use, a new study suggests ... medical devices get created in the first place. The ... as little loss of health as possible and to ...
Breaking Medicine News(10 mins):Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: